Myovant Sciences (NYSE:MYOV) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Myovant Sciences beat estimated earnings by 26.67%, reporting an EPS of $-0.22 versus an estimate of $-0.3.
Revenue was up $75.43 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 13.06% drop in the share price the next day.
Here's a look at Myovant Sciences's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.57 | -0.60 | -0.38 | -0.33 |
| EPS Actual | -0.63 | -0.68 | -0.23 | -0.67 |
| Revenue Estimate | 64.66M | 53.92M | 71.40M | 57.05M |
| Revenue Actual | 57.57M | 54.44M | 77.90M | 41.06M |
To track all earnings releases for Myovant Sciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
